Koji Yutaka, Tomiyama Hirofumi, Yamada Jiko, Yambe Minoru, Motobe Kohki, Shiina Kazuki, Yamashina Akira
Second Department of Internal Medicine, Tokyo Medical University, Japan.
Hypertens Res. 2007 Mar;30(3):243-7. doi: 10.1291/hypres.30.243.
We examined the influence of metabolic syndrome (MetS) on the relationship between arterial stiffness and the risk of coronary artery disease (CAD). In 396 subjects (age, 63+/-11 years) who underwent coronary angiography, multiple linear regression analysis demonstrated that the brachial-ankle pulse wave velocity (PWV), but not the presence of MetS, was a significant determinant of the number of diseased coronary arteries (beta=0.10, p<0.05), even though both the brachial-ankle PWV and the number of diseased coronary arteries were higher in subjects with MetS (n=100) than in those without MetS (n=296). However, in subjects with MetS, multiple linear regression analysis demonstrated that the brachial-ankle PWV was not a significant determinant of the number of diseased coronary arteries. The brachial-ankle PWV values were classified into tertile ranges in subjects with and without MetS. The number of diseased coronary arteries increased significantly with an increase in the tertile number of the brachial-ankle PWV in the subjects without MetS (tertile 1=1.00+/-0.86, tertile 2=1.29+/-1.01, and tertile 3=1.45+/-1.05), but not in those with MetS. In conclusion, the results of this study suggest that arterial stiffness is a marker of the risk of CAD in subjects without MetS, whereas in subjects with MetS, the syndrome may directly produce clinically significant atherosclerotic stenosis of the coronary arteries independent of its significant promotion of the development of coronary atherosclerosis via an increase of arterial stiffness.
我们研究了代谢综合征(MetS)对动脉僵硬度与冠状动脉疾病(CAD)风险之间关系的影响。在396名接受冠状动脉造影的受试者(年龄63±11岁)中,多元线性回归分析表明,肱踝脉搏波速度(PWV)而非MetS的存在是病变冠状动脉数量的重要决定因素(β=0.10,p<0.05),尽管MetS患者(n=100)的肱踝PWV和病变冠状动脉数量均高于无MetS患者(n=296)。然而,在MetS患者中,多元线性回归分析表明肱踝PWV并非病变冠状动脉数量的重要决定因素。将有和无MetS受试者的肱踝PWV值分为三分位数范围。在无MetS的受试者中,病变冠状动脉数量随肱踝PWV三分位数的增加而显著增加(三分位数1=1.00±0.86,三分位数2=1.29±1.01,三分位数3=1.45±1.05),但在MetS患者中并非如此。总之,本研究结果表明,动脉僵硬度是无MetS受试者CAD风险的标志物,而在MetS患者中,该综合征可能直接导致具有临床意义的冠状动脉粥样硬化狭窄,而不依赖于其通过增加动脉僵硬度显著促进冠状动脉粥样硬化的发展。